Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 3 boards, counting each seat separately. Longest: Bone Biologics Corp, 3 years.
Bone Biologics Corp
Director
Beyond Air Inc.
Director
SAB Biotherapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 25, 2026 | Dyne Therapeutics Inc. | Open-market sale | −2,362 | $20.37 | $48,114 |
| May 13, 2026 | Dyne Therapeutics Inc. | Open-market sale | −1,448 | $18.36 | $26,585 |
| Apr 1, 2026 | Dyne Therapeutics Inc. | Open-market sale | −5,727 | $18.64 | $106,751 |
| Feb 12, 2026 | Dyne Therapeutics Inc. | Grant or award | +65,000 | — | — |
| Mar 31, 2025 | Dyne Therapeutics Inc. | Grant or award | +66,100 | — | — |
| Mar 4, 2025 | Editas Medicine Inc. | Open-market sale | −4,109 | $1.71 | $7,026 |
| Aug 14, 2024 | Beyond Air Inc. | Open-market purchase | +39,266 | $0.40 | $15,706 |
| May 20, 2024 | Editas Medicine Inc. | Open-market sale | −22,337 | $5.61 | $125,311 |
| Mar 2, 2024 | Editas Medicine Inc. | Grant or award | +35,300 | — | — |
| Mar 2, 2024 | Editas Medicine Inc. | Grant or award | +25,966 | — | — |
| May 17, 2023 | Editas Medicine Inc. | Grant or award | +77,900 | — | — |
| Mar 16, 2023 | Beyond Air Inc. | Open-market purchase | +2,000 | $6.82 | $13,640 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.